ADMA
ADMA Biologics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -5.9% ·
aandelenstroom -3.6% ·
netto nieuwe posities -6.2%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | -1 | 146.16M | $1.22B | +9 | −12 |
| Q1 2026 | 111 | -5 | 163.83M | $1.48B | +7 | −12 |
| Q4 2025 | 115 | +1 | 163.64M | $2.98B | +1 | — |
| Q3 2025 | 19 | +1 | 92.34M | $1.35B | +3 | −3 |
| Q2 2025 | 16 | -1 | 89.41M | $1.63B | +1 | −2 |
| Q1 2025 | 14 | 0 | 31.71M | $629.12M | — | — |
| Q4 2024 | 14 | +2 | 37.00M | $634.64M | +2 | — |
| Q3 2024 | 11 | -2 | 23.86M | $476.89M | — | −2 |
| Q2 2024 | 13 | — | 23.97M | $268.00M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 36.47M | — | $664.18M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 2 | The Vanguard Group ✦ (passief) | 21.36M | — | $389.03M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passief) | 12.08M | +5.6% | $219.95M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 5.91M | +4.3% | $107.69M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Fidelity (FMR) ✦ | 3.21M | — | $58.50M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 6 | Renaissance Technologies ✦ | 3.15M | -11.3% | $57.29M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 2.14M | +1.3% | $38.96M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Two Sigma Investments ✦ | 1.20M | -46.7% | $21.89M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Millennium Management ✦ | 1.14M | -47.1% | $20.68M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Wellington Management ✦ | 931.94K | +893.3% | $16.97M | 0.0% | ▲ Add | 5 | SEC ↗ ×7 |
| 11 | D. E. Shaw & Co. ✦ | 832.56K | -45.4% | $15.16M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 459.88K | -11.5% | $8.37M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 13 | Arrowstreet Capital ✦ | 360.56K | -67.7% | $6.57M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 108.99K | -33.6% | $1.98M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | Norges Bank ✦ (passief) | 30.13K | 0.0% | $548,722 | 0.0% | Held | 3 | SEC ↗ |
| 16 | Marshall Wace ✦ | 21.09K | Nieuw | $384,048 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Marshall Wace | $384,048 | 0.0% |
Verlaten
| Point72 Asset Management | $16.82M | was 0.0% |
| Citadel Advisors | $4.79M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 355 houders, 211.31M aandelen, $1.84B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.